[
    [
        {
            "time": "2020-02-17",
            "original_text": "高瓴资本23亿全额认购凯莱英定增，这个“卖铲子”的行业为何让资本汹涌而至？",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "凯莱英",
                    "定增",
                    "再融资新规"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "高瓴资本23亿全额认购凯莱英定增，这个“卖铲子”的行业为何让资本汹涌而至？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-17",
            "original_text": "恒瑞医药卡培他滨片过评，默沙东失眠疗法获批",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "卡培他滨片",
                    "仿制药一致性评价",
                    "默沙东"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药卡培他滨片过评，默沙东失眠疗法获批",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-02-17",
            "original_text": "资金净流入224亿元，近38亿抢筹公牛集团",
            "features": {
                "keywords": [
                    "资金净流入",
                    "公牛集团"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "消费电子"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "资金净流入224亿元，近38亿抢筹公牛集团",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-02-17",
            "original_text": "陆股通净买入53.62亿元，连续5日净买入",
            "features": {
                "keywords": [
                    "陆股通",
                    "净买入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "陆股通净买入53.62亿元，连续5日净买入",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-02-17",
            "original_text": "高瓴资本拟23亿入股A股企业凯莱英，还是药明康德百济神州股东",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "凯莱英",
                    "药明康德",
                    "百济神州"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "高瓴资本拟23亿入股A股企业凯莱英，还是药明康德百济神州股东",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]